These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 9469188

  • 1. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA.
    Med J Aust; 1998 Jan 19; 168(2):76-8. PubMed ID: 9469188
    [No Abstract] [Full Text] [Related]

  • 2. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S, Ploybutr S, Nitiyanant W, Peerapatdit T, Vichayanrat A.
    J Med Assoc Thai; 1995 Nov 19; 78(11):578-85. PubMed ID: 8576667
    [Abstract] [Full Text] [Related]

  • 3. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
    Fölsch UR, Lembcke B.
    Internist (Berl); 1991 Dec 19; 32(12):699-707. PubMed ID: 1823561
    [No Abstract] [Full Text] [Related]

  • 4. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR.
    Clin Invest Med; 1995 Aug 19; 18(4):312-7. PubMed ID: 8549018
    [Abstract] [Full Text] [Related]

  • 5. [Acarbose in the treatment of non-insulin-dependent diabetes mellitus; a new principle].
    Drent ML, van der Veen EA.
    Ned Tijdschr Geneeskd; 1992 Feb 15; 136(7):308-10. PubMed ID: 1538796
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Combined therapy with insulin and alpha-glucosidase inhibitor].
    Watanabe K, Kawamori R.
    Nihon Rinsho; 1997 Nov 15; 55 Suppl():261-6. PubMed ID: 9434478
    [No Abstract] [Full Text] [Related]

  • 16. [The use of the alpha-glucosidase inhibitor acarbose for the treatment of type-2 diabetes mellitus in secondary sulfanilamide resistance].
    Gendeleka GF.
    Lik Sprava; 1997 Nov 15; (6):105-7. PubMed ID: 9589946
    [Abstract] [Full Text] [Related]

  • 17. [Improvement in diabetes therapy. Interview by Heike E. Nähtke].
    Mehnert H.
    Fortschr Med; 1990 Sep 20; 108(27):72, 75. PubMed ID: 2227754
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Alpha glucosidase inhibitor].
    Katsuta H, Ishida H.
    Nihon Rinsho; 2006 Dec 28; 64 Suppl 9():637-45. PubMed ID: 17458296
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.